1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Pure Autonomic Failure: new trials by email Literature Review of Pure Autonomic Failure trials Research Report on Pure Autonomic Failure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fipamezole in Neurogenic Orthostatic Hypotension Placebo, Fipamezole - Symptomatic Neurogenic Orthostatic Hypotension (NOH), Parkinson's Disease | Phase 2 | Unknown | Juvantia Pharma Ltd | 24 | 2008-09-01 | 2008-10-01 |
Hypotension, Orthostatic (1) · Multiple System Atrophy (1) · Olivopontocerebellar Atrophies (1) · Parkinson Disease (1) · Shy-Drager Syndrome (1) · Striatonigral Degeneration (1)
Autonomic Nervous System Diseases (1) · Basal Ganglia Diseases (1) · Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Cerebellar Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Heredodegenerative Disorders, Nervous System (1) · Hypotension (1) · Movement Disorders (1) · Nervous System Diseases (1) · Neurodegenerative Diseases (1) · Orthostatic Intolerance (1) · Parkinsonian Disorders (1)
fipamezole (1)
France (1) · Portugal (1)